4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-014409
Head of R&D, CSO gave up 572 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Rodino-Klapac Louise · Head of R&D, CSO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-01 | Shares withheld for taxes : show line 1 in the form | −572 | $75.05 | $42,929 | 65,327 | D |
Loading xslF345X03/doc4.xml…